A two-page summary on newly marketed drugs including the therapeutic classification, indications, pharmacology and pharmacokinetics, summary of clinical trials, reactions and interactions, dosing, comparative cost and place in therapy. This publication is issued up to 24 times per year.
Sample publication of a Drug Evaluation
Below are the titles of this publication issued in 2009 and 2010.
|
Tadalafil |
October 2010 |
||
|
Saxagliptin |
September 2010 |
||
|
Certolizumab |
August 2010 |
||
|
Azacitabine |
July 2010 |
||
|
Eculizumab |
June 2010 |
||
|
Dronedarone |
May 2010 |
||
|
Golimumab |
April 2010 |
||
|
Eplerenone |
March 2010 |
||
|
Idebenone |
February 2010 |
||
|
Romiplostim |
January 2010 |
||
|
Doripenem |
December 2009 |
||
|
Romiplostim |
January 2010 |
||
|
Methyl Aminolevulinate Hydrochloride (Aktinic keratoses & Basal Cell Carcinoma) |
November 2009 |
||
|
Epelrenone |
October 2009 |
||
|
Ethinyl estradiol/Drospirenone (Yaz®) |
September 2009 |
||
|
Zoster Vaccine |
August 2009 |
||
|
Loteprednol Etabonate 0.5% |
July 2009 |
||
|
Loteprednol Etabonate 0.2% |
June 2009 |
||
|
Desvenlafaxine Succinate |
May 2009 |
||
|
Ciclesonide Nasal Spray |
April 2009 |
||
|
Ustekinumab Injection |
March 2009 |
||
|
Olmesartan Medoxomil & Olmesartan Medoxomil/Hydrochlorothiazide |
February 2009 |
||
|
Insulin Glulisine |
January 2009 |